Financhill
Buy
58

FSROF Quote, Financials, Valuation and Earnings

Last price:
$2.00
Seasonality move :
0%
Day range:
$2.00 - $2.00
52-week range:
$1.96 - $2.00
Dividend yield:
3.03%
P/E ratio:
15.48x
P/S ratio:
2.26x
P/B ratio:
6.38x
Volume:
500
Avg. volume:
17
1-year change:
--
Market cap:
$349.3M
Revenue:
$158.3M
EPS (TTM):
$0.13

Dividend Data

Dividend yield
3.03%
Sector average: 0.75%
Annualized payout
$0.00
Paid quarterly
Payout ratio
28.63%
EPS $0.03
Dividend increase track record
0 years

Most Recent Dividend Payouts

Ex-dividend date
October 6
In 85 days
Ex-dividend amount
$0.02
Payment date
October 14
In 93 days

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Declaration Date Ex-Dividend Date Payable Date Record Date Amount
02/27/2025 10/06/2025 10/14/2025 10/07/2025 $0.02
02/27/2025 04/02/2025 04/10/2025 04/03/2025 $0.02
02/16/2024 09/26/2024 10/04/2024 09/27/2024 $0.04
02/16/2024 03/14/2024 03/22/2024 03/15/2024 $0.04

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock